share_log

UPDATE: Pfizer-BioNTech Say Requests Based On Data From Pivotal Phase 3 Trial In Adolescents 12 To 15 Years Of Age With Or Without Prior Evidence Of Sars-Cov-2 Infection

Benzinga Real-time News ·  Apr 10, 2021 00:57
UPDATE: Pfizer-BioNTech Say Requests Based On Data From Pivotal Phase 3 Trial In Adolescents 12 To 15 Years Of Age With Or Without Prior Evidence Of Sars-Cov-2 Infection
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment